PATENT CLAIM ANALYSIS

Application Number: 15776094
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "236200"]

Abstract:
Compounds of formula I or a stereoisomer or pharmaceutically-acceptable salt thereof, are useful in the modulation of IL-12, IL-23 and/or IFNα, by acting on Tyk-2 to cause signal transduction inhibition.

Claim (Index 9):
A method of treating a disease, comprising administering to a patient in need of such treatment a therapeutically-effective amount of a compound according to  claim 1 , wherein the disease is an inflammatory or autoimmune disease.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 93.0
- Lexical Diversity: 1.13333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15034915', '15289437', '14441213', '14441193', '15480787']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8560756198508733
- 35 USC 102 Novelty (BERT): 0.5908115195989787
- Combined Prediction Score: 0.8295492098256838
- Mean Citation Score: 569.3277099999998
- Max Citation Score: 593.6887
- Similarity Product: 421.03795415169

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test